<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">In a similar fashion, GI dysbiosis has been associated with IBD. Fecal samples from CD patients exhibit higher levels of 
 <italic>Enterobacteriaceae</italic>, 
 <italic>Fusobacterium</italic>, and 
 <italic>Enterococcus faecalis</italic>
 <sup>
  <xref ref-type="bibr" rid="CR34">34</xref>â€“
  <xref ref-type="bibr" rid="CR36">36</xref>
 </sup>. Levels of fecal 
 <italic>Escherichia coli</italic> positively correlate, while fecal levels of 
 <italic>Bacteroides</italic> negatively correlate with age of CD patients
 <sup>
  <xref ref-type="bibr" rid="CR37">37</xref>
 </sup>. On the contrary, CD patients have been noted with an overall decrease in microbial diversity due to lower levels of 
 <italic>Firmicutes</italic> with 43 ribotypes identified in healthy patients compared to only 13 in CD patients
 <sup>
  <xref ref-type="bibr" rid="CR38">38</xref>
 </sup>. In the colon, 
 <italic>Lachnospiraceae</italic>, 
 <italic>Firmicutes</italic>, and 
 <italic>Bacteriodetes</italic> have all been shown to be reduced in the mucosa in CD patients relative to healthy controls
 <sup>
  <xref ref-type="bibr" rid="CR39">39</xref>,
  <xref ref-type="bibr" rid="CR40">40</xref>
 </sup>. Previous studies have identified adherent-invasive 
 <italic>Escherichia coli</italic> in active phases of CD and 
 <italic>Mycobacterium avium paratuberculosis</italic> as potential causal roles of CD, suggesting a link between CD patients and opportunistic pathogens that prime the environment for ensuing alterations in intestinal permeability and inflammation
 <sup>
  <xref ref-type="bibr" rid="CR41">41</xref>,
  <xref ref-type="bibr" rid="CR42">42</xref>
 </sup>.
</p>
